Progesterone and its metabolite allopregnanolone promote invasion of human glioblastoma cells through metalloproteinase‑9 and cSrc kinase

Bello-Alvarez,Claudia; Zamora-Sánchez,Carmen J.; Peña-Gutiérrez,Karla M.; Camacho-Arroyo,Ignacio

doi:10.3892/ol.2023.13809

Progesterone and its metabolite allopregnanolone promote invasion of human glioblastoma cells through metalloproteinase‑9 and cSrc kinase

Authors:
- Claudia Bello-Alvarez
- Carmen J. Zamora-Sánchez
- Karla M. Peña-Gutiérrez
- Ignacio Camacho-Arroyo
View Affiliations

Affiliations: Unidad de Investigación en Reproducción Humana, Instituto Nacional de Perinatología‑Facultad de Química, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico
Published online on: April 13, 2023 https://doi.org/10.3892/ol.2023.13809
Article Number: 223
Copyright: © Bello-Alvarez et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Glioblastomas are the most aggressive and common primary brain tumors in adults. Glioblastoma cells have a great capacity to migrate and invade the brain parenchyma, often reaching the contralateral hemisphere. Progesterone (P4) and its metabolite, allopregnanolone (3α‑THP), promote the migration and invasion of human glioblastoma‑derived cells. P4 induces migration in glioblastoma cells by the activation of the proto‑oncogene tyrosine‑protein kinase Src (cSrc) and focal adhesion kinase (Fak). In breast cancer cells, cSrc and Fak promote invasion by increasing the expression and activation of extracellular matrix metalloproteinases (MMPs). However, the mechanism of action by which P4 and 3a-THP promote invasion in glioblastoma cells remains unclear. The effects of P4 and 3α‑THP on the protein expression levels of MMP‑2 and ‑9 and the participation of cSrc in progestin effects in U251 and U87 human glioblastoma‑derived cells were evaluated. It was determined by western blotting that the P4 increased the protein expression level of MMP‑9 in U251 and U87 cells, and 3α‑THP increased the protein expression level of MMP‑9 in U87 cells. None of these progestins modified MMP‑2 protein expression levels. The increase in MMP‑9 expression was reduced when the intracellular progesterone receptor and cSrc expression were blocked with small interfering RNAs. Cell invasion induced by P4 and 3α‑THP was also blocked by inhibiting cSrc activity with PP2 or by cSrc gene silencing. These results suggest that P4 and its metabolite 3α‑THP induce the invasion of glioblastoma cells by increasing MMP‑9 expression through the cSrc kinase family. The results of this study provide information of interest in the context of targeted therapies against molecular pathways involved in glioblastoma invasion.

View Figures

View References

1	Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C and Barnholtz-Sloan JS: CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2011–2015. Neuro Oncol. 20:iv1–iv86. 2018. View Article : Google Scholar : PubMed/NCBI
2	Giese A, Bjerkvig R, Berens ME and Westphal M: Cost of migration: Invasion of malignant gliomas and implications for treatment. J Clin Oncol. 21:1624–1636. 2003. View Article : Google Scholar : PubMed/NCBI
3	Patel A, Sabbineni H, Clarke A and Somanath PR: Novel roles of Src in cancer cell epithelial-to-mesenchymal transition, vascular permeability, microinvasion and metastasis. Life Sci. 157:52–61. 2016. View Article : Google Scholar : PubMed/NCBI
4	Cortes-Reynosa P, Robledo T, Macias-Silva M, Wu SV and Salazar EP: Src kinase regulates metalloproteinase-9 secretion induced by type IV collagen in MCF-7 human breast cancer cells. Matrix Biol. 27:220–231. 2008. View Article : Google Scholar : PubMed/NCBI
5	Gautam J, Banskota S, Lee H, Lee YJ, Jeon YH, Kim JA and Jeong BS: Down-regulation of cathepsin S and matrix metalloproteinase-9 via Src, a non-receptor tyrosine kinase, suppresses triple-negative breast cancer growth and metastasis. Exp Mol Med. 50:1–14. 2018. View Article : Google Scholar : PubMed/NCBI
6	Zhou W, Yu X, Sun S, Zhang X, Yang W, Zhang J, Zhang X and Jiang Z: Increased expression of MMP-2 and MMP-9 indicates poor prognosis in glioma recurrence. Biomed Pharmacother. 118:1093692019. View Article : Google Scholar : PubMed/NCBI
7	Forsyth PA, Wong H, Laing TD, Rewcastle NB, Morris DG, Muzik H, Leco KJ, Johnston RN, Brasher PM, Sutherland G and Edwards DR: Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Br J Cancer. 79:1828–1835. 1999. View Article : Google Scholar : PubMed/NCBI
8	Kondraganti S, Mohanam S, Chintala SK, Kin Y, Jasti SL, Nirmala C, Lakka SS, Adachi Y, Kyritsis AP, Ali-Osman F, et al: Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion. Cancer Res. 60:6851–6855. 2000.PubMed/NCBI
9	Trabert B, Sherman ME, Kannan N and Stanczyk FZ: Progesterone and breast cancer. Endocr Rev. 41:320–344. 2020. View Article : Google Scholar : PubMed/NCBI
10	Grindstad T, Richardsen E, Andersen S, Skjefstad K, Khanehkenari MR, Donnem T, Ness N, Nordby Y, Bremnes RM, Al-Saad S and Busund LT: Progesterone receptors in prostate cancer: Progesterone receptor B is the isoform associated with disease progression. Sci Rep. 8:1–11. 2018. View Article : Google Scholar
11	Bello-Alvarez C and Camacho-Arroyo I: Impact of sex in the prevalence and progression of glioblastomas: The role of gonadal steroid hormones. Biol Sex Differ. 12:282021. View Article : Google Scholar : PubMed/NCBI
12	Fu XD, Goglia L, Sanchez AM, Flamini M, Giretti MS, Tosi V, Genazzani AR and Simoncini T: Progesterone receptor enhances breast cancer cell motility and invasion via extranuclear activation of focal adhesion kinase. Endocr Relat Cancer. 17:431–443. 2010. View Article : Google Scholar : PubMed/NCBI
13	Grochans S, Cybulska AM, Simińska D, Korbecki J, Kojder K, Chlubek D and Baranowska-Bosiacka I: Epidemiology of glioblastoma multiforme-literature review. Cancers (Basel). 14:24122022. View Article : Google Scholar : PubMed/NCBI
14	Germán-Castelán L, Manjarrez-Marmolejo J, González-Arenas A and Camacho-Arroyo I: Intracellular progesterone receptor mediates the increase in glioblastoma growth induced by progesterone in the rat brain. Arch Med Res. 47:419–426. 2016. View Article : Google Scholar : PubMed/NCBI
15	Bello-Alvarez C, Moral-Morales AD, González-Arenas A and Camacho-Arroyo I: Intracellular progesterone receptor and cSrc protein working together to regulate the activity of proteins involved in migration and invasion of human glioblastoma cells. Front Endocrinol (Lausanne). 12:6402982021. View Article : Google Scholar : PubMed/NCBI
16	Piña-Medina AG, Hansberg-Pastor V, González-Arenas A, Cerbón M and Camacho-Arroyo I: Progesterone promotes cell migration, invasion and cofilin activation in human astrocytoma cells. Steroids. 105:19–25. 2016. View Article : Google Scholar : PubMed/NCBI
17	Zamora-Sánchez CJ, Hansberg-Pastor V, Salido-Guadarrama I, Rodríguez-Dorantes M and Camacho-Arroyo I: Allopregnanolone promotes proliferation and differential gene expression in human glioblastoma cells. Steroids. 119:36–42. 2017. View Article : Google Scholar : PubMed/NCBI
18	Zamora-Sánchez CJ, Bello-Alvarez C, Rodríguez-Dorantes M and Camacho-Arroyo I: Allopregnanolone promotes migration and invasion of human glioblastoma cells through the protein tyrosine kinase c-Src activation. Int J Mol Sci. 23:49962022. View Article : Google Scholar : PubMed/NCBI
19	Melfi S, Guevara MM, Bonalume V, Ruscica M, Colciago A, Simoncini T and Magnaghi V: Src and phospho-FAK kinases are activated by allopregnanolone promoting Schwann cell motility, morphology and myelination. J Neurochem. 141:165–178. 2017. View Article : Google Scholar : PubMed/NCBI
20	Pirkmajer S and Chibalin AV: Serum starvation: Caveat emptor. Am J Physiol Cell Physiol. 301:C272–C279. 2011. View Article : Google Scholar : PubMed/NCBI
21	Jabłońska-Trypuć A, Matejczyk M and Rosochacki S: Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. J Enzyme Inhib Med Chem. 31:177–183. 2016. View Article : Google Scholar : PubMed/NCBI
22	Global Cancer Observatory, .
23	van Linde ME, Brahm CG, de Witt Hamer PC, Reijneveld JC, Bruynzeel AME, Vandertop WP, van de Ven PM, Wagemakers M, van der Weide HL, Enting RH, et al: Treatment outcome of patients with recurrent glioblastoma multiforme: A retrospective multicenter analysis. J Neurooncol. 135:183–192. 2017. View Article : Google Scholar : PubMed/NCBI
24	Gkretsi V and Stylianopoulos T: Cell adhesion and matrix stiffness: Coordinating cancer cell invasion and metastasis. Front Oncol. 8:1452018. View Article : Google Scholar : PubMed/NCBI
25	Quintero-Fabián S, Arreola R, Becerril-Villanueva E, Torres-Romero JC, Arana-Argáez V, Lara-Riegos J, Ramírez-Camacho MA and Alvarez-Sánchez ME: Role of matrix metalloproteinases in angiogenesis and cancer. Front Oncol. 9:13702019. View Article : Google Scholar : PubMed/NCBI
26	Quesnel A, Karagiannis GS and Filippou PS: Extracellular proteolysis in glioblastoma progression and therapeutics. Biochim Biophys Acta Rev Cancer. 1874:1884282020. View Article : Google Scholar : PubMed/NCBI
27	Cai HP, Wang J, Xi SY, Ni XR, Chen YS, Yu YJ, Cen ZW, Yu ZH, Chen FR, Guo CC, et al: Tenascin-c mediated vasculogenic mimicry formation via regulation of MMP2/MMP9 in glioma. Cell Death Dis. 10:1–14. 2019. View Article : Google Scholar : PubMed/NCBI
28	Mirabdaly S, Komi DE, Shakiba Y, Moini A and Kiani A: Effects of temozolomide on U87MG glioblastoma cell expression of CXCR4, MMP2, MMP9, VEGF, anti-proliferatory cytotoxic and apoptotic properties. Mol Biol Rep. 47:1187–1197. 2020. View Article : Google Scholar : PubMed/NCBI
29	Chen CJ, Shang HS, Huang YL, Tien N, Chen YL, Hsu SY, Wu RSC, Tang CL, Lien JC, Lee MH, et al: Bisdemethoxycurcumin suppresses human brain glioblastoma multiforme GBM 8401 cell migration and invasion via affecting NF-κB and MMP-2 and MMP-9 signaling pathway in vitro. Environ Toxicol. 37:2388–2397. 2022. View Article : Google Scholar : PubMed/NCBI
30	Li Q, Chen B, Cai J, Sun Y, Wang G, Li Y, Li R, Feng Y, Han B, Li J, et al: Comparative analysis of matrix metalloproteinase family members reveals that MMP9 predicts survival and response to temozolomide in patients with primary glioblastoma. PLoS One. 11:e01518152016. View Article : Google Scholar : PubMed/NCBI
31	González-Agüero G, Gutiérrez AA, González-Espinosa D, Solano JD, Morales R, González-Arenas A, Cabrera-Muñoz E and Camacho-Arroyo I: Progesterone effects on cell growth of U373 and D54 human astrocytoma cell lines. Endocrine. 32:129–135. 2007. View Article : Google Scholar : PubMed/NCBI
32	Hernández-Hernández OT, González-García TK and Camacho-Arroyo I: Progesterone receptor and SRC-1 participate in the regulation of VEGF, EGFR and cyclin D1 expression in human astrocytoma cell lines. J Steroid Biochem Mol Biol. 132:127–134. 2012. View Article : Google Scholar : PubMed/NCBI
33	González-Arenas A, Valadez-Cosmes P, Jiménez-Arellano C, López-Sánchez M and Camacho-Arroyo I: Progesterone-induced blocking factor is hormonally regulated in human astrocytoma cells, and increases their growth through the IL-4R/JAK1/STAT6 pathway. J Steroid Biochem Mol Biol. 144:463–470. 2014. View Article : Google Scholar : PubMed/NCBI
34	Strom JO, Theodorsson A and Theodorsson E: Hormesis and female sex hormones. Pharmaceuticals (Basel). 4:726–740. 2011. View Article : Google Scholar : PubMed/NCBI
35	Atif F, Yousuf S and Stein DG: Anti-tumor effects of progesterone in human glioblastoma multiforme: Role of PI3K/Akt/mTOR signaling. J Steroid Biochem Mol Biol. 146:62–73. 2015. View Article : Google Scholar : PubMed/NCBI
36	Diviccaro S, Cioffi L, Falvo E, Giatti S and Melcangi RC: Allopregnanolone: An overview on its synthesis and effects. J Neuroendocrinol. 34:e129962022. View Article : Google Scholar : PubMed/NCBI
37	Thomas P and Pang Y: Membrane progesterone receptors: Evidence for neuroprotective, neurosteroid signaling and neuroendocrine functions in neuronal cells. Neuroendocrinology. 96:162–71. 2012. View Article : Google Scholar : PubMed/NCBI
38	Pang Y, Dong J and Thomas P: Characterization, neurosteroid binding and brain distribution of human membrane progesterone receptors δ and {epsilon} (mPRδ and mPR{epsilon}) and mPRδ involvement in neurosteroid inhibition of apoptosis. Endocrinology. 154:283–295. 2013. View Article : Google Scholar : PubMed/NCBI
39	Lamba V, Yasuda K, Lamba JK, Assem M, Davila J, Strom S and Schuetz EG: PXR (NR1I2): Splice variants in human tissues, including brain, and identification of neurosteroids and nicotine as PXR activators. Toxicol Appl Pharmacol. 199:251–265. 2004. View Article : Google Scholar : PubMed/NCBI
40	Frye CA, Koonce CJ and Walf AA: The pregnane xenobiotic receptor, a prominent liver factor, has actions in the midbrain for neurosteroid synthesis and behavioral/neural plasticity of female rats. Front Syst Neurosci. 8:602014. View Article : Google Scholar : PubMed/NCBI
41	Belelli D and Gee KW: 5 alpha-pregnan-3 alpha,20 alpha-diol behaves like a partial agonist in the modulation of GABA-stimulated chlride ion uptake by synaptoneurosomes. Eur J Pharmacol. 167:173–176. 1989. View Article : Google Scholar : PubMed/NCBI
42	Zamora-Sánchez CJ, Hernández-Vega AM, Gaona-Domínguez S, Rodríguez-Dorantes M and Camacho-Arroyo I: 5alpha-dihydroprogesterone promotes proliferation and migration of human glioblastoma cells. Steroids. 163:1087082020. View Article : Google Scholar : PubMed/NCBI
43	González-Flores O, Beyer C, Gómora-Arrati P, García-Juárez M, Lima-Hernández FJ, Soto-Sánchez A and Etgen AM: A role for Src kinase in progestin facilitation of estrous behavior in estradiol-primed female rats. Horm Behav. 58:223–229. 2010. View Article : Google Scholar : PubMed/NCBI
44	Bergmann N, Delbridge C, Gempt J, Feuchtinger A, Walch A, Schirmer L, Bunk W, Aschenbrenner T, Liesche-Starnecker F and Schlegel J: The intratumoral heterogeneity reflects the intertumoral subtypes of glioblastoma multiforme: A regional immunohistochemistry analysis. Front Oncol. 10:4942020. View Article : Google Scholar : PubMed/NCBI
45	Becker AP, Sells BE, Haque SJ and Chakravarti A: Tumor heterogeneity in glioblastomas: From light microscopy to molecular pathology. Cancers (Basel). 13:1–25. 2021. View Article : Google Scholar
46	Motaln H, Koren A, Gruden K, Ramšak Ž, Schichor C and Lah TT: Heterogeneous glioblastoma cell cross-talk promotes phenotype alterations and enhanced drug resistance. Oncotarget. 6:40998–41017. 2015. View Article : Google Scholar : PubMed/NCBI
47	Stettner MR, Wang W, Nabors LB, Bharara S, Flynn DC, Grammer JR, Gillespie GY and Gladson CL: Lyn kinase activity is the predominant cellular Src kinase activity in glioblastoma tumor cells. Cancer Res. 65:5535–5543. 2005. View Article : Google Scholar : PubMed/NCBI
48	Ramachandran RK, Sørensen MD, Aaberg-Jessen C, Hermansen SK and Kristensen BW: Expression and prognostic impact of matrix metalloproteinase-2 (MMP-2) in astrocytomas. PLoS One. 12:e01722342017. View Article : Google Scholar : PubMed/NCBI
49	Hsia DA, Mitra SK, Hauck CR, Streblow DN, Nelson JA, Ilic D, Huang S, Li E, Nemerow GR, Leng J, et al: Differential regulation of cell motility and invasion by FAK. J Cell Biol. 160:753–767. 2003. View Article : Google Scholar : PubMed/NCBI
50	Hsieh HL, Yu MC, Cheng LC, Chu MY, Huang TH, Yeh TS and Tsai MM: Quercetin exerts anti-inflammatory effects via inhibiting tumor necrosis factor-α-induced matrix metalloproteinase-9 expression in normal human gastric epithelial cells. World J Gastroenterol. 28:1139–1158. 2022. View Article : Google Scholar : PubMed/NCBI
51	Yeatman TJ: A renaissance for SRC. Nat Rev Cancer. 4:470–480. 2004. View Article : Google Scholar : PubMed/NCBI
52	Mitra SK and Schlaepfer DD: Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol. 18:516–523. 2006. View Article : Google Scholar : PubMed/NCBI
53	Boonyaratanakornkit V and Edwards DP: Receptor mechanisms mediating non-genomic actions of sex steroids. Semin Reprod Med. 25:139–153. 2007. View Article : Google Scholar : PubMed/NCBI
54	Liu DT, Carter NJ, Wu XJ, Hong WS, Chen SX and Zhu Y: Progestin and nuclear progestin receptor are essential for upregulation of metalloproteinase in zebrafish preovulatory follicles. Front Endocrinol (Lausanne). 9:5172018. View Article : Google Scholar : PubMed/NCBI
55	Ishrat T, Sayeed I, Atif F, Hua F and Stein DG: Progesterone and allopregnanolone attenuate blood-brain barrier dysfunction following permanent focal ischemia by regulating the expression of matrix metalloproteinases. Exp Neurol. 226:183–190. 2010. View Article : Google Scholar : PubMed/NCBI
56	Yan C and Boyd DD: Regulation of matrix metalloproteinase gene expression. J Cell Physiol. 211:19–26. 2007. View Article : Google Scholar : PubMed/NCBI